Exelixis, Inc. (EXEL) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-02-10 20:54:20 ET
Exelixis, Inc. (EXEL) Q4 2025 Earnings Call February 10, 2026 5:00 PM EST
Company Participants
Andrew Peters - Senior Vice President of Strategy
Michael Morrissey - CEO, President & Director
Christopher Senner - Executive VP & CFO
P. Haley - Executive Vice President of Commercial
Dana Aftab - Executive Vice President of Research & Development
...
Read the full article on Seeking Alpha
For further details see:
Exelixis, Inc. (EXEL) Q4 2025 Earnings Call Transcript
Exelixis Inc.
NASDAQ: EXEL
EXEL Trading
-1.02% G/L:
$40.89 Last:
352,368 Volume:
$41.57 Open:
EXEL Latest News
February 28, 2026 04:57:00 am
3 Reasons Exelixis Stock Could Deliver Market?Beating Returns Over the Next Decade
February 24, 2026 04:05:00 pm
Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in March
February 24, 2026 10:58:00 am
Oncology Market Set to Nearly Triple: Here Are Five Companies Leading the Charge
February 20, 2026 04:05:00 pm
Exelixis: The Cash?Generating Biotech That I Think Deserves a Closer Look in 2026
EXEL Stock Data
$11,614,618,641
260,551,394
1.54%
313
N/A
Biotechnology & Life Sciences
Healthcare
US
Alameda
